AMP 2026

Unmet Needs in Deep Venous Arterialization Technology

10/07/2026

In this video, interventional cardiologist Zola N'Dandu, MD, from Ascension Sacred Heart in Pensacola, Florida, discusses one of the presentations he gave at the 2026 Amputation Prevention Symposium on what is needed to successfully perform deep venous arterialization.

© 2026 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Vascular Disease Management or HMP Global, their employees, and affiliates.

Stay in the Know

Vascular Disease Management Newsletter

News

Deep Learning

Deep Learning Model Predicts Hepatocellular Carcinoma Progression Following Transarterial Chemoembolization

10/09/2026

Laura Simson, MA

A prediction model combining deep learning, radiomics, and clinical data demonstrated promising performance in predicting disease progression following transarterial chemoembolization in patients with hepatocellular carcinoma.

A prediction model combining...

10/09/2026

Vascular Disease Management

AngioDynamics

AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer

10/08/2026

LATHAM, N.Y.--(BUSINESS WIRE)--Oct. 8, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment...

LATHAM, N.Y.--(BUSINESS...

10/08/2026

Vascular Disease Management

Bioresorbable Scaffolds

REVA Medical Announces Motiv Sirolimus-Eluting Bioresorbable Vascular Scaffold Live Case and Late-Breaking BTK Trial Results at VIVA26

10/08/2026

SAN DIEGO -- REVA Medical, LLC announced the successful completion of a live case demonstration featuring the MOTIV® sirolimus-eluting bioresorbable vascular scaffold and the presentation of late-breaking clinical results from the...

SAN DIEGO -- REVA Medical,...

10/08/2026

Cath Lab Digest

Lower-Extremity & Stroke Intervention

VIVA26: New Results From AGILITY, PERFORMANCE II, and XTRACT

10/07/2026

Final late-breaking VIVA26 studies reported new data on the Revello™ covered stent for iliac artery disease, Neuroguard IEP carotid stenting outcomes, and early real-world use of the Rotarex™ atherectomy system in CLTI.

Final late-breaking VIVA26...

10/07/2026

Cath Lab Digest

Chronic Venous Disease

Medtronic Announces New Prospective, Global Clinical Evidence From the Spectrum Program for VenaSeal™ Closure System in Advanced Chronic Venous Disease

10/07/2026

Vascular Disease Management

Peripheral Intervention

VIVA26: New Results From POWER PAD II, DISRUPT PAD BTK II, PROMISE III, ELEGANCE, and a TCOT Trial

10/07/2026

Late-breaking VIVA26 studies reported on IVL for calcified PAD, transdermal oxygen therapy after LE revascularization, transcatheter arterialization for no-option CLTI, and DES outcomes in complex femoropopliteal disease.

Late-breaking VIVA26 studies...

10/07/2026

Cath Lab Digest

Pulmonary Embolism

VIVA26: New Results From HI-PEITHO, STORM-PE, and TRUST

10/07/2026

Three late-breaking VIVA26 studies reported new data on bleeding risk with ultrasound-facilitated catheter-directed thrombolysis, wearable-based functional recovery after intermediate-high-risk PE, and Laguna Thrombectomy System™ safety and...

Three late-breaking VIVA26...

10/07/2026

Cath Lab Digest

Peripheral Intervention

VIVA26: New Results From SELUTION4SFA, SirPAD, SUCCESS PTA, CADET-PAD, Esprit BTK, and MOTIV BTK

10/07/2026

Six late-breaking VIVA26 studies reported new data on sirolimus-based balloon and resorbable scaffold therapies, as well as adjunctive pharmacologic treatment, for patients with PAD and chronic limb-threatening ischemia.

Six late-breaking VIVA26 studies...

10/07/2026

Cath Lab Digest

iliac artery disease

VIVA 2026: BD's Revello Covered Stent Shows 97.2% Primary Patency in AGILITY Trial

10/07/2026

Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac...

Data through 9 months of...

10/07/2026

Cath Lab Digest

Pulmonary Embolism

New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism

10/07/2026

Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and anticoagulation alone translate to patients’ everyday recovery.

Wearable-derived data provide...

10/07/2026

Cath Lab Digest

Unmet Needs in Deep Venous Arterialization Technology

© 2026 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Vascular Disease Management or HMP Global, their employees, and affiliates.

Stay in the Know

News

HMP Global Products

Events